key: cord-1019940-r0vfz7l6
authors: He, Fei; Xia, Xian; Nie, Danwen; Yang, Hongmei; Jiang, Yongzhong; Huo, Xixiang; Guo, Fang; Fang, Bin; Hu, Bing; Jiang, Honglin; Zhan, Faxian; Lv, Jing
title: Respiratory bacterial pathogen spectrum among COVID-19 infected and non-COVID-19 virus infected pneumonia patients
date: 2020-09-03
journal: Diagn Microbiol Infect Dis
DOI: 10.1016/j.diagmicrobio.2020.115199
sha: a79ddf36c3940aa921f55ce3ac8f605e3ef04129
doc_id: 1019940
cord_uid: r0vfz7l6

COVID-19 positive (194) and negative (212) pneumonia patients were selected to analyze bacterial pathogens coinfection. Results showed that 50% COVID-19 patients were coinfected or carried bacterial pathogens. Bordetella pertussis infection rate was significantly higher in positive patients. Consequently, preventions should be taken to control bacterial pathogens coinfection in COVID-19 patients.

Up to 10 CEST, 24 August 2020, 23,311,719 COVID-19 infected patients were confirmed in the world according to the report of WHO [1] . It has attracted great attention from all over the world. COVID-19 is a respiratory pathogen and its infection could result in severe pneumonia [2] . Coinfection with bacterial pathogens was one of the reasons why COVID-19 is fatal [3, 4] . Identification of coinfection pathogens play a great important role in treatment of COVID-19 infected patients.

Recently, COVID-19 infected pneumonia patients with coinfection of Mycoplasma pneumonia, Legionella pneumophila were found in Qingdao and Wuhan [5] . However, the sample size was limited and only several bacterial pathogens were analyzed.

infected samples in the previous study. Hence, bacterial pathogens dynamic change in COVID-19 positive pneumonia patients couldn't be identified. In this study, 406 samples including COVID-19 positive and negative pneumonia patients were collected and 14 respiratory bacterial pathogens were tested. The study aims to more accurately evaluate the coinfection of COVID-19 with common bacterial pathogens.

During February 8 to February 15, 2020 in Suizhou city, Hubei province, 2216 pneumonia patients were diagnosed based on chest X-ray or computed tomography (small slide shadows and interstitial changed, obvious extrapulmonary bands, or even ground-glass opacity and infiltration shadows, lung consolidation and pleural Furthermore, there were five deaths in the COVID-19 positive patients. In these five patients, two were coinfected with B. pertussis and three patients were detected with P.

aeruginosa (Table S2 ). One of the two patient was first infected by COVID-19 and then infected by B. pertussis and P. aeruginosa (Table S3 ). The bacterial coinfection might be one of the reason why disease worsen among these three death patients. B.

pertussis causes cough to spread the pathogens in the air which can further enhance the pathogens transmission [11] . It also has the ability to inhibit the function of the host's immune system and cause various respiratory disorders [12] . Accordingly, B. 

A Novel Coronavirus from Patients with Pneumonia in China

Co-infections: potentially lethal and unexplored in COVID-19

Fatal superimposed bacterial sepsis in a healthy Coronavirus (COVID-19) patient

Precautions are Needed for COVID-19 Patients with Coinfection of Common Respiratory Pathogens

Chinese National Health Commission. Prevention and control plan for novel

Prediction of the pathogens that are the cause of pneumonia by the battlefield hypothesis

Real-time PCR detection of Pseudomonas aeruginosa in clinical and municipal wastewater and genotyping of the ciprofloxacin-resistant isolates

Infant Pertussis: Who Was the Source?

Immunomodulation in the pathogenesis of Bordetella pertussis infection and disease

Medical expert group of Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology. A quick guide to the diagnosis and treatment of pneumonia infected by new coronavirus

Kucers' the use of antibiotics

Research progress of Lianhua Qingwen in the treatment of influenza

Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host? Front Immunol

We are grateful to Dr. Bingqing Zhu